Literature DB >> 16091900

Localized pulmonary infection associated with Mycobacterium tilburgii in an HIV-infected patient.

M Kolditz1, M Halank, P Spornraft-Ragaller, H Schmidt, G Höffken.   

Abstract

The case of an HIV-infected patient with low CD4+ cell count and localized pulmonary infection associated with Mycobacterium tilburgii, a recently recognized atypical mycobacterial species, is reported. Diagnosis was confirmed by repeated detection of mycobacterial DNA in lung biopsy specimens. After surgical removal of the pulmonary nodules, treatment with antimycobacterial combination therapy led to a complete and sustained recovery of the respiratory symptoms.M. tilburgii so far has only been described to cause disseminated infection in three patients, two of them suffering from acquired immunodeficiency syndrome. To our knowledge, this is the first report of localized pulmonary disease attributed to this mycobacterial species. As it responds to antimycobacterial combination therapy, efforts to establish the diagnosis using PCR methods in patients with suspected pulmonary disease due to mycobacteria other than tuberculosis should be undertaken.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16091900     DOI: 10.1007/s15010-005-4118-0

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  7 in total

1.  "Mycobacterium tilburgii," a newly described, uncultivated opportunistic pathogen.

Authors:  Tara N Palmore; Yvonne R Shea; Patricia S Conville; Frank G Witebsky; Victoria L Anderson; Irene P Rupp Hodge; Steven M Holland
Journal:  J Clin Microbiol       Date:  2009-03-04       Impact factor: 5.948

2.  IL-12Rβ1 deficiency and disseminated Mycobacterium tilburgii disease.

Authors:  Kinda Schepers; Liliane Schandené; Jacinta Bustamante; Jean-Paul Van Vooren; Maylis de Suremain; Jean-Laurent Casanova; Jean Cyr Yombi; Frédérique Jacobs; Françoise Mascart; Jean-Christophe Goffard
Journal:  J Clin Immunol       Date:  2013-10-10       Impact factor: 8.317

3.  "Mycobacterium tilburgii" infection in two immunocompromised children: importance of molecular tools in culture-negative mycobacterial disease diagnosis.

Authors:  Nico G Hartwig; Adilia Warris; Esther van de Vosse; Adri G M van der Zanden; Tanja Schülin-Casonato; Jakko van Ingen; Rob van Hest
Journal:  J Clin Microbiol       Date:  2011-10-19       Impact factor: 5.948

4.  Disseminated infection with Mycobacterium tilburgii in a male immunocompromised patient.

Authors:  Sarah Temmerman; Linos Vandekerckhove; Erica Sermijn; Dirk Vogelaers; Geert Claeys; Mario Vaneechoutte; Piet Cools; Steven Callens
Journal:  J Clin Microbiol       Date:  2014-02-12       Impact factor: 5.948

5.  Molecular characterization of a novel fastidious mycobacterium causing lepromatous lesions of the skin, subcutis, cornea, and conjunctiva of cats living in Victoria, Australia.

Authors:  J A Fyfe; C McCowan; C R O'Brien; M Globan; C Birch; P Revill; V R D Barrs; J Wayne; M S Hughes; S Holloway; R Malik
Journal:  J Clin Microbiol       Date:  2007-12-05       Impact factor: 5.948

6.  "Mycobacterium tilburgii" infections.

Authors:  Dirk Wagner; Margreet Vos; Anton G M Buiting; Annerose Serr; Anneke M C Bergmans; Winfried Kern; Leo M Schouls
Journal:  Emerg Infect Dis       Date:  2006-03       Impact factor: 6.883

7.  Functional Immune Reconstitution by Interleukin-2 Adjunctive Therapy for HIV/Mycobacterial Co-infection.

Authors:  Jan Heyckendorf; Sven Philip Aries; Ulf Greinert; Elvira Richter; Holger Schultz; Christoph Lange
Journal:  Emerg Infect Dis       Date:  2015-09       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.